HHS Autism Action Plan, Reorganization, and Shutdown Impacts

This week’s headline from the Department of Health and Human Services is the launch of a comprehensive Autism Action Plan, signaling a major federal push to address the rapidly increasing rates of autism spectrum disorder in the United States. According to Social Current, this multi-pronged initiative ties together new research funding, clinical guidance changes, and national campaigns designed to improve services and outcomes for individuals and families affected by autism. Central to the plan is a new FDA label indication for leucovorin, a treatment for cerebral folate deficiency linked with some forms of autism, now covered under state Medicaid programs. The National Institutes of Health will back this with a series of confirmatory trials and expanded safety studies, moving quickly to establish clearer clinical protocols and better access. Meanwhile, the FDA is collaborating with manufacturers to update acetaminophen labeling and promote further research into potential risks during pregnancy, aiming to provide clearer guidance and better safeguard maternal and child health. These policy shifts land amidst one of the most turbulent times for HHS in decades. The department is undergoing a large-scale reorganization, merging five agencies into a brand-new Administration for a Healthy America and streamlining core functions. As of April, HHS began the process of reducing staff by nearly 20,000—about 25% of its workforce—impacting agencies like the CDC, FDA, National Institutes of Health, and Centers for Medicare & Medicaid Services. The stated goal, according to an official announcement, is to become “more responsive and efficient, while ensuring that Medicare, Medicaid, and other essential health services remain intact.” Still, these changes raise significant concerns about capacity, continuity, and public health response. Layered onto all this is the uncertainty of the extended government shutdown. With congressional negotiations at a standstill, most health agencies have frozen new policy announcements, regulatory updates, and grant disbursements. The Senate has failed to pass a continuing resolution, leaving federal programs—including those run by HHS—in limbo, and leaving states and local governments to grapple with the consequences. Safety-net hospitals, Medicaid providers, and local health departments are particularly exposed, facing delays in payments and guidance. The shutdown also halts critical research and enforcement activity, impacting not just American citizens, but businesses, organizations, and global partners tied into U.S. public health efforts. In the latest grants policy update, HHS announced major changes effective October 1: all grants now require stricter civil rights certifications, and budget revisions over 10% demand prior agency approval, tightening oversight and demanding clearer accountability from grantees. For partnerships, HHS is doubling down on collaborations with state Medicaid agencies and launching a natio This content was created in partnership and with the help of Artificial Intelligence AI.